Practices of pharmacies that compound extemporaneous formulations

American Journal of Health-System Pharmacy

Volumn 64, Issue 13, 2007, Pages 1403-1409

  Treadway, Angela K ^a,b,f   Craddock, Deeatra ^a,c   Leff, Richard ^a,d,e  

^a TEXAS TECH UNIVERSITY   (United States)

^b VA North Texas Health Care System   (United States)

^c Community Pharmacy ^*  (United States)

^d Dallas/Fort Worth Metroplex Campus ^*  (United States)

^e Children's Medical Center   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Administration; Caffeine citrate; Central nervous system stimulants; Compounding; Control, quality; Data collection; Documentation; Education, pharmaceutical; Equipment; Excipients; Expiration dates; Labeling; Pharmacy; Quality assurance; Stability; Standards

Indexed keywords

CAFFEINE CITRATE; EXCIPIENT;

ARTICLE; ASEPSIS; DRUG FORMULATION; DRUG LABELING; DRUG STORAGE; EXPIRATION DATE; HEALTH CARE PRACTICE; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; STAFF TRAINING;

EID: 34347388843     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060251     Document Type: Article

References (21)

1. Nahata MC. Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother. 1999; 33:247-9.
2. Kaye T. The quandary of compounding for MCOs: administrative costs, risks, and waste. Managed Care. 2003; 12:42-8.
3. Perrin JH. Hazard of compounded anesthetic gel. Am J Health-Syst Pharm. 2005; 62:1445-6. Letter.
4. Federal Bureau of Investigation. List of drugs Courtney claims to have diluted. http://kansascity.fbi.gov/pressrel/2002/ kcmostate042202.htm (accessed 2006 Mar 7).
5. Gebhart F. Fatal meningitis links to compounding by California pharmacy. Drug Topics. 2001; 13:32.
6. Selenic D, Dobson DR, Jensen B et al. Enterobactere cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy. Am J Health-Syst Pharm. 2003; 60:1440-6.
7. Kastango ES, Bradshaw BD. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health-Syst Pharm. 2004; 61:1928-38.
8. Morris AM, Schneider PJ, Pedersen CA et al. National survey of quality assurance activities for pharmacy-compounded sterile preparations. Am J Health-Syst Pharm. 2003; 60:2567-76.
9. Driscoll DF. Compounding TPN admixtures: then and now. J Parenter Enteral Nutr. 2003; 27:433-8.
10. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health-Syst Pharm. 2000; 57:1150-69.
11. Pharmaceutical compounding - sterile preparations (general information chapter 797). In: The United States pharmacopeia, 27th rev., and The national formulary, 22nd ed. Rockville, MD: United States Pharmacopeial Convention; 2004.
12. Pharmaceutical compounding - nonsterile preparations (general information chapter 795). In: The United States pharmacopeia, 25th rev., and The national formulary, 20th ed. Rockville, MD: United States Pharmacopeial Convention; 2001.
13. Joint Commission on Accreditation of Healthcare Organizations. Joint Commission to survey compliance with new USP-NF chapter on compounding sterile preparations. Jt Comm Perspect. 2004; 24:4-5.
14. Winckler SC. Extemporaneous compounding: a return to regulatory limbo? J Pain Palliat Care Pharmacother. 2002; 16:71-8.
15. Flynn EA, Pearson RE, Barker K. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health-Syst Pharm. 1997; 54:904-12.
16. Crawford S, Dombrowski S. Extemporaneous compounding activities and the associated informational needs of pharmacists. Am J Hosp Pharm. 1991; 48:1205-10.
17. Santell J, Kamalich R. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities. Am J Health-Syst Pharm. 1996; 53:2591-605.
18. Draft guidelines on compounding of nonsterile products in pharmacies. Am J Hosp Pharm. 1993; 50:1452-61.
19. Good compounding practices (general chapter 1075). In: The United States pharmacopeia, 25th rev., and The national formulary, 20th ed. Rockville, MD: United States Pharmacopeial Convention; 2004.
20. Dillman DA. Mail and internet surveys: the tailored design method. 2nd ed. New York: Wiley; 2000.
21. Cafcit (caffeine citrate) package insert. Evansville, IN: Mead Johnson; 2004 Nov.